John P. Longenecker
Founder chez Jpl Biotech
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Andreas Wicki | M | 64 |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | 23 ans |
Thomas Thaler | M | 68 |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The private company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. | 13 ans |
Garnet Peck | M | 93 |
Purdue University
| 57 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Richard J. Wanstall | M | 55 | 4 ans | |
Joseph Yanchik | M | 60 | 17 ans | |
Frank Alexander Mlynarczyk | M | 81 |
Purdue University
| 3 ans |
James A. Tompkins | M | - |
Purdue University
| 7 ans |
Wayne Clinton Ramsey | M | - |
Purdue University
| 5 ans |
Stephen B. Howell | M | 79 |
DepoTech Corp.
DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | 10 ans |
William Pete Yutmeyer | M | - |
Purdue University
| 5 ans |
John Lewicki | M | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 17 ans |
Lawrence D. Stone | M | - |
Purdue University
| 3 ans |
Gregory J. Robertson | M | - |
Australian National University
| 6 ans |
Mari Elka Pangestu | M | 67 |
Australian National University
| 5 ans |
William W. Reid | M | 75 |
Purdue University
| 6 ans |
Charles Sigal | M | 72 |
Purdue University
| 8 ans |
Richard Ghalie | M | 66 |
Favrille, Inc.
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | 2 ans |
Robert S. Weiner | M | - |
Purdue University
| 4 ans |
Edward L. Erickson | M | 76 |
DepoTech Corp.
DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | 5 ans |
Kwok Keung Ma | M | 64 |
Australian National University
| 5 ans |
Elaine Heron | M | 76 |
Purdue University
| 8 ans |
Carl Adams | M | - |
Purdue University
| 4 ans |
Adel A. Zakaria | M | - |
Purdue University
| 1 ans |
Thomas J. Sanders | M | - |
Purdue University
| 3 ans |
Ralph Bowman | M | - |
Purdue University
| 4 ans |
Jacob A. Davis | M | 87 |
Purdue University
| 3 ans |
Timothy V. Moore | M | - |
Purdue University
| 4 ans |
Wyman C. Harris | M | - |
Purdue University
| 2 ans |
Kevin D. Welsh | M | - |
Purdue University
| 4 ans |
Phil Keating | M | - |
Purdue University
| 3 ans |
Larry E. Bagwell | M | - |
Purdue University
| 1 ans |
Terry Prince | M | - |
Purdue University
| 4 ans |
Wong Kar Gee Hung | F | 75 |
Purdue University
| 4 ans |
Stephen Michael Rudolph | M | 73 |
Purdue University
| 4 ans |
Michael W. Hyer | M | - |
Purdue University
| 3 ans |
Paul W. Hemmer | M | - |
Purdue University
| 4 ans |
James D. Pardee | M | 80 |
Purdue University
| 4 ans |
Otto C. Guedelhoefe | M | - |
Purdue University
| 4 ans |
Mark Emory Vaughan | M | - |
Purdue University
| 3 ans |
Edward Karl Goldberg | M | - |
Purdue University
| 4 ans |
Mohammad Dasron Hamid | M | - |
Australian National University
| 1 ans |
Bill Chen | M | - |
Purdue University
| 3 ans |
Greg Donaldson | M | - |
Purdue University
| 4 ans |
G. Newton Freeman | M | - |
Purdue University
| 2 ans |
Charles Bryan | M | - |
Purdue University
| 1 ans |
Robert A. Floyd | M | - |
Purdue University
| 3 ans |
Timothy M. Harden | M | - |
Purdue University
| 4 ans |
Najib Adel Qubain | M | 80 |
Purdue University
| 1 ans |
Abdullah bin Sepien | M | 77 |
Australian National University
| 3 ans |
Elsa Johnson | F | - |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | 6 ans |
Larry Estes | M | - |
Purdue University
| 4 ans |
James L. Apple | M | 78 |
Purdue University
| 4 ans |
Khaled bin Eissa | M | - |
Purdue University
| 4 ans |
Thomas P. McDuffee | M | - |
Purdue University
| 4 ans |
Manahar Shah | M | - |
Purdue University
| 1 ans |
Stuart C. Stock | M | - |
Purdue University
| 4 ans |
Steven T. Thornton | M | 67 | 5 ans | |
Donald B. Villwock | M | - |
Purdue University
| 4 ans |
John C. Gutheil | M | 67 |
Favrille, Inc.
| - |
Thomas L. Fisher | M | 78 |
Purdue University
| 4 ans |
William George | M | 81 |
Purdue University
| 3 ans |
John A. Edwardson | M | 74 |
Purdue University
| 4 ans |
Karl G. Boyd | M | 72 |
Purdue University
| 4 ans |
Vanessa Castagna | F | 73 |
Purdue University
| 4 ans |
Richard W. Davies | M | 77 |
Purdue University
| 1 ans |
Michael Alan Shuter | M | 70 |
Purdue University
| 4 ans |
Thomas Chalfant | M | 74 |
Purdue University
| 4 ans |
René Lewin | M | 77 |
Purdue University
| 4 ans |
Mark H. Webbink | M | 73 |
Purdue University
| 4 ans |
Thomas H. Strang | M | 73 |
Purdue University
| 4 ans |
Donald J. Esses | M | 72 |
Purdue University
| 4 ans |
William C. Ulland | M | 83 |
Purdue University
| 1 ans |
Michael T. Riordan | M | 73 |
Purdue University
| 4 ans |
Forest J. Farmer | M | 83 |
Purdue University
| 4 ans |
James T. Rhodes | M | 82 |
Purdue University
| 3 ans |
Bala S. Manian | M | 77 |
Purdue University
| 3 ans |
Mohammad A. Aslami | M | 70 |
Purdue University
| 4 ans |
Fred Middleton | M | 74 |
Favrille, Inc.
| 7 ans |
Gary G. Schlarbaum | M | - |
Purdue University
| 15 ans |
Gerald A. Fagen | M | - |
Purdue University
| 4 ans |
Alice M. Wei | F | 60 |
Favrille, Inc.
| 6 ans |
Phil Raimondo | M | - |
Purdue University
| 2 ans |
Charles L. Whittington | M | - |
Purdue University
| 4 ans |
Glenn Gregory Kautt | M | - |
Purdue University
| 4 ans |
Steven Webster | M | 72 |
Purdue University
| 4 ans |
Prame Chopra | M | 70 |
Australian National University
| 3 ans |
Robert E. Brooks | M | 77 |
Purdue University
| 4 ans |
Jim Woody | M | 81 |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | 4 ans |
Richard M. Murawski | M | 75 |
Favrille, Inc.
| 6 ans |
William O. Fifield | M | - |
Purdue University
| 4 ans |
Tom Lynch | M | - |
Purdue University
| 4 ans |
David Lucas | M | - |
Purdue University
| 4 ans |
Arda Minocherhomjee | M | 70 |
Favrille, Inc.
| 3 ans |
Charles Bryan | M | 76 |
Purdue University
| 1 ans |
Scott Lutzke | M | - |
Purdue University
| 4 ans |
Ronald Parratt | M | 75 |
Purdue University
| 4 ans |
Larry Joe Walker | M | - |
Purdue University
| 4 ans |
James Lee Mumford | M | - |
Purdue University
| 4 ans |
Michael L. Eagle | M | 76 |
Favrille, Inc.
| 6 ans |
Khai Meng Ang | M | 64 |
Australian National University
| 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 90 | 90,00% |
Australie | 7 | 7,00% |
Îles Cayman | 2 | 2,00% |
Royaume-Uni | 1 | 1,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- John P. Longenecker
- Réseau Personnel